Addenbrooke's professor Krish Chatterjee has been awarded the 2025 Gerald D. Aurbach Award for Outstanding Translational Research by the Endocrine Society.
He is one of 14 leading endocrinologists who were selected for the Society’s prestigious 2025 Laureate Awards, which recognise the highest achievements in endocrinology research and care, and which are regarded as the highest honours in the field.
This particular award recognises outstanding contributions to research that accelerates the transition of scientific discoveries into clinical applications.
He said:
It is a privilege to accept this award which also represents the efforts of many clinical and scientist colleagues as well as patients taking part in our research, without whom our contributions to advancing knowledge and changing health outcomes in endocrine disorders would not have been possible.
Professor Krish Chatterjee
Professor Chatterjee is a professor of endocrinology at the Institute of Metabolic Science at the University of Cambridge, consultant endocrinologist at Cambridge University Hospitals, and director of the National Institute for Health Research (NIHR) Cambridge Clinical Research Facility.
He is distinguished for his contribution to the molecular basis of endocrine disorders and its application to clinical medicine. His research focuses on genetic and molecular endocrinology, exploring disorders including resistance to thyroid hormone and PPARgamma gene defects associated with lipodystrophic insulin resistance.
He has translated his research into biochemical and genetic tests and biomarkers that constitute an internationally recognised diagnostic service for disorders of thyroid hormone action and which inform therapeutic approaches in these disorders.
The Endocrine Society will present the awards to the winners at ENDO 2025 (opens in a new tab), the Society’s annual meeting, being held next July 12-15 in San Francisco.